)
)
VolitionRX Investor Relations Material
Latest events
Q3 2024
VolitionRX
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from VolitionRX Ltd
Access all reports
VolitionRX Ltd is a multi-national epigenetics company that specializes in the development of blood tests through its proprietary Nucleosomics™ platform. This platform is designed to create simple, easy-to-use, and cost-effective blood tests aimed at diagnosing and monitoring a variety of life-altering diseases, including some cancers and diseases related to NETosis, such as sepsis and COVID-19. The company is headquartered in Henderson, Nevada, and its shares are listed on the NYSE American under the ticker symbol VNRX.
Key slides for VolitionRX Ltd
Status Update
VolitionRX Ltd
Status Update
VolitionRX Ltd
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
VNRX
Country
🇺🇸 United States